Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Only abstract available.

Data source

Reference
Reference Type:
publication
Title:
Sensitization to dimethyl fumarate with multiple concurrent patch test reactions
Author:
Lammintausta K, et al.
Year:
2010
Bibliographic source:
Contact Dermatitis; 62(2):88-96.

Materials and methods

Type of sensitisation studied:
skin
Study type:
other: 9 patients were tested
Principles of method if other than guideline:
Patch testing with dimethyl fumarate (DMF) in concentrations of 0.1-0.00001% was carried out in 37 patients. Diethyl fumarate (DEF), diethyl maleate (DEM), dimethyl maleate (DMM), ethyl acrylate (EA), methyl acrylate (MA), and methyl methacrylate (MMA) were also tested with a dilution series at equimolar concentrations.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Dimethyl maleate
EC Number:
210-848-5
EC Name:
Dimethyl maleate
Cas Number:
624-48-6
Molecular formula:
C6H8O4
IUPAC Name:
dimethyl (Z)-but-2-enedioate
Details on test material:
- Name of test material (as cited in study report): dimethyl maleate (DMM)

Method

Type of population:
general
Ethical approval:
not specified
Subjects:
- Number of subjects exposed: 37

Results and discussion

Results of examinations:
DMM reactions were seen in all 9 patients tested.

Applicant's summary and conclusion

Conclusions:
In a sensitization study dimethyl maleate showed reactions in all 9 patients tested.
Under the given conditions DMM exhibited skin sensitising potential in human patients.